Key facts
- It has raised $780K; the latest was Angel (individual) ($30K) in Jan 2025.
- Notable investors include Creative Destruction Lab, Founders Factory, i.d.e.a. Fund, Innovation Factory (Hamilton), LEAD (Venture Capital) — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for AgeRate
- ·The full record, as it builds
Funding rounds
No funding rounds for AgeRate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AgeRate
Developer of a biotechnology platform designed to provide health insights through epigenetic testing. The company's platform uses DNA-methylation patterns to compare biological age to chronological age with the help of epigenetic testing service, enabling customers to slow down their aging rate through healthy lifestyle interventions such as diet and exercise.
- Sector
- Healthcare
- HQ
- Hamilton, Canada
- Founded
- 2018
- Employees
- 6
- Website
- agerate.com/
- Ownership
- Privately Held (backing)
AgeRate doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AgeRate shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AgeRate in its N-PORT filings yet. We sweep new filings monthly.